HEADER TRANSFERASE 30-JUN-14 4TWC TITLE 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL)THIAZOLE-4- CARBOXAMIDE TITLE 2 DERIVATIVES AS POTENT INHIBITORS OF CK1D/E CAVEAT 4TWC BOG A 1006 HAS WRONG CHIRALITY AT ATOM C1 BOG A 1008 HAS CAVEAT 2 4TWC WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE I ISOFORM DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CKID,TAU-PROTEIN KINASE CSNK1D; COMPND 5 EC: 2.7.11.1,2.7.11.26; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK1D, HCKID; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CK1D, CK1E, PHOSPHORYLATION, SMALL MOLECULE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.BISCHOF,L.LEBAN,M.ZAJA,A.GROTHEY,B.RADUNSKY,O.OTHERSEN,S.STROBL, AUTHOR 2 D.VITT,U.KNIPPSCHILD REVDAT 3 20-DEC-23 4TWC 1 HETSYN REVDAT 2 29-JUL-20 4TWC 1 COMPND REMARK HETNAM SITE REVDAT 1 08-OCT-14 4TWC 0 JRNL AUTH J.BISCHOF,J.LEBAN,M.ZAJA,A.GROTHEY,B.RADUNSKY,O.OTHERSEN, JRNL AUTH 2 S.STROBL,D.VITT,U.KNIPPSCHILD JRNL TITL 2-BENZAMIDO-N-(1H-BENZO[D]IMIDAZOL-2-YL) JRNL TITL 2 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS POTENT INHIBITORS OF JRNL TITL 3 CK1D/E. JRNL REF AMINO ACIDS V. 43 1577 2012 JRNL REFN ISSN 0939-4451 JRNL PMID 22331384 JRNL DOI 10.1007/S00726-012-1234-X REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 78490 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 4085 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5819 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.3400 REMARK 3 BIN FREE R VALUE SET COUNT : 308 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4790 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 837 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.11000 REMARK 3 B22 (A**2) : 0.39000 REMARK 3 B33 (A**2) : -0.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.094 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.098 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.793 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5198 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4943 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7025 ; 1.572 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11383 ; 0.957 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 624 ; 5.665 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 248 ;35.152 ;22.863 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 938 ;14.276 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;17.272 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 738 ; 0.147 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5762 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1291 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2380 ; 3.014 ; 2.436 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2379 ; 3.013 ; 2.435 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2979 ; 4.247 ; 3.629 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4TWC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000202390. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82702 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 28.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1CKI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NACL, 1.4 M (NH4)2SO4, 0.1 M BIS REMARK 280 -TRIS, PH 5.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 67.36050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 219 REMARK 465 ALA B 219 REMARK 465 THR B 220 REMARK 465 LYS B 221 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1200 O HOH A 1242 1.50 REMARK 500 O HOH A 1350 O HOH B 1381 1.79 REMARK 500 O HOH A 1295 O HOH A 1456 1.88 REMARK 500 O HOH B 1303 O HOH B 1505 1.88 REMARK 500 O HOH B 1200 O HOH B 1440 1.97 REMARK 500 OD1 ASN B 78 O HOH B 1101 1.98 REMARK 500 O HOH A 1227 O HOH A 1447 2.01 REMARK 500 O HOH B 1160 O HOH B 1188 2.10 REMARK 500 N GLU A 2 O HOH A 1101 2.12 REMARK 500 O GLY B 75 O HOH B 1389 2.14 REMARK 500 O HOH B 1304 O HOH B 1494 2.14 REMARK 500 O1 SO4 B 1004 O HOH B 1102 2.19 REMARK 500 O HOH A 1237 O HOH A 1331 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1170 O HOH B 1161 2656 2.08 REMARK 500 O HOH A 1177 O HOH B 1102 2555 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 115 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 115 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ILE B 68 CG1 - CB - CG2 ANGL. DEV. = -14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 8 -22.90 -142.71 REMARK 500 ASN A 123 10.59 87.20 REMARK 500 ASP A 128 55.04 -151.22 REMARK 500 ASP A 149 98.94 74.73 REMARK 500 HIS A 162 19.82 56.48 REMARK 500 LYS A 294 77.13 -108.78 REMARK 500 ASN B 7 15.62 36.65 REMARK 500 ASN B 123 10.48 80.44 REMARK 500 ASP B 149 99.05 78.20 REMARK 500 LYS B 294 58.04 -108.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1414 DISTANCE = 6.72 ANGSTROMS REMARK 525 HOH A1429 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A1520 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH B1242 DISTANCE = 8.86 ANGSTROMS DBREF 4TWC A 1 295 UNP P48730 KC1D_HUMAN 1 295 DBREF 4TWC B 1 295 UNP P48730 KC1D_HUMAN 1 295 SEQADV 4TWC ASN A 13 UNP P48730 ARG 13 ENGINEERED MUTATION SEQADV 4TWC ASN B 13 UNP P48730 ARG 13 ENGINEERED MUTATION SEQRES 1 A 295 MET GLU LEU ARG VAL GLY ASN ARG TYR ARG LEU GLY ASN SEQRES 2 A 295 LYS ILE GLY SER GLY SER PHE GLY ASP ILE TYR LEU GLY SEQRES 3 A 295 THR ASP ILE ALA ALA GLY GLU GLU VAL ALA ILE LYS LEU SEQRES 4 A 295 GLU CYS VAL LYS THR LYS HIS PRO GLN LEU HIS ILE GLU SEQRES 5 A 295 SER LYS ILE TYR LYS MET MET GLN GLY GLY VAL GLY ILE SEQRES 6 A 295 PRO THR ILE ARG TRP CYS GLY ALA GLU GLY ASP TYR ASN SEQRES 7 A 295 VAL MET VAL MET GLU LEU LEU GLY PRO SER LEU GLU ASP SEQRES 8 A 295 LEU PHE ASN PHE CYS SER ARG LYS PHE SER LEU LYS THR SEQRES 9 A 295 VAL LEU LEU LEU ALA ASP GLN MET ILE SER ARG ILE GLU SEQRES 10 A 295 TYR ILE HIS SER LYS ASN PHE ILE HIS ARG ASP VAL LYS SEQRES 11 A 295 PRO ASP ASN PHE LEU MET GLY LEU GLY LYS LYS GLY ASN SEQRES 12 A 295 LEU VAL TYR ILE ILE ASP PHE GLY LEU ALA LYS LYS TYR SEQRES 13 A 295 ARG ASP ALA ARG THR HIS GLN HIS ILE PRO TYR ARG GLU SEQRES 14 A 295 ASN LYS ASN LEU THR GLY THR ALA ARG TYR ALA SER ILE SEQRES 15 A 295 ASN THR HIS LEU GLY ILE GLU GLN SER ARG ARG ASP ASP SEQRES 16 A 295 LEU GLU SER LEU GLY TYR VAL LEU MET TYR PHE ASN LEU SEQRES 17 A 295 GLY SER LEU PRO TRP GLN GLY LEU LYS ALA ALA THR LYS SEQRES 18 A 295 ARG GLN LYS TYR GLU ARG ILE SER GLU LYS LYS MET SER SEQRES 19 A 295 THR PRO ILE GLU VAL LEU CYS LYS GLY TYR PRO SER GLU SEQRES 20 A 295 PHE ALA THR TYR LEU ASN PHE CYS ARG SER LEU ARG PHE SEQRES 21 A 295 ASP ASP LYS PRO ASP TYR SER TYR LEU ARG GLN LEU PHE SEQRES 22 A 295 ARG ASN LEU PHE HIS ARG GLN GLY PHE SER TYR ASP TYR SEQRES 23 A 295 VAL PHE ASP TRP ASN MET LEU LYS PHE SEQRES 1 B 295 MET GLU LEU ARG VAL GLY ASN ARG TYR ARG LEU GLY ASN SEQRES 2 B 295 LYS ILE GLY SER GLY SER PHE GLY ASP ILE TYR LEU GLY SEQRES 3 B 295 THR ASP ILE ALA ALA GLY GLU GLU VAL ALA ILE LYS LEU SEQRES 4 B 295 GLU CYS VAL LYS THR LYS HIS PRO GLN LEU HIS ILE GLU SEQRES 5 B 295 SER LYS ILE TYR LYS MET MET GLN GLY GLY VAL GLY ILE SEQRES 6 B 295 PRO THR ILE ARG TRP CYS GLY ALA GLU GLY ASP TYR ASN SEQRES 7 B 295 VAL MET VAL MET GLU LEU LEU GLY PRO SER LEU GLU ASP SEQRES 8 B 295 LEU PHE ASN PHE CYS SER ARG LYS PHE SER LEU LYS THR SEQRES 9 B 295 VAL LEU LEU LEU ALA ASP GLN MET ILE SER ARG ILE GLU SEQRES 10 B 295 TYR ILE HIS SER LYS ASN PHE ILE HIS ARG ASP VAL LYS SEQRES 11 B 295 PRO ASP ASN PHE LEU MET GLY LEU GLY LYS LYS GLY ASN SEQRES 12 B 295 LEU VAL TYR ILE ILE ASP PHE GLY LEU ALA LYS LYS TYR SEQRES 13 B 295 ARG ASP ALA ARG THR HIS GLN HIS ILE PRO TYR ARG GLU SEQRES 14 B 295 ASN LYS ASN LEU THR GLY THR ALA ARG TYR ALA SER ILE SEQRES 15 B 295 ASN THR HIS LEU GLY ILE GLU GLN SER ARG ARG ASP ASP SEQRES 16 B 295 LEU GLU SER LEU GLY TYR VAL LEU MET TYR PHE ASN LEU SEQRES 17 B 295 GLY SER LEU PRO TRP GLN GLY LEU LYS ALA ALA THR LYS SEQRES 18 B 295 ARG GLN LYS TYR GLU ARG ILE SER GLU LYS LYS MET SER SEQRES 19 B 295 THR PRO ILE GLU VAL LEU CYS LYS GLY TYR PRO SER GLU SEQRES 20 B 295 PHE ALA THR TYR LEU ASN PHE CYS ARG SER LEU ARG PHE SEQRES 21 B 295 ASP ASP LYS PRO ASP TYR SER TYR LEU ARG GLN LEU PHE SEQRES 22 B 295 ARG ASN LEU PHE HIS ARG GLN GLY PHE SER TYR ASP TYR SEQRES 23 B 295 VAL PHE ASP TRP ASN MET LEU LYS PHE HET SO4 A1001 5 HET SO4 A1002 5 HET SO4 A1003 5 HET SO4 A1004 5 HET GOL A1005 6 HET BOG A1006 20 HET 37J A1007 35 HET BOG A1008 20 HET SO4 B1001 5 HET SO4 B1002 5 HET SO4 B1003 5 HET SO4 B1004 5 HET GOL B1005 6 HET GOL B1006 6 HET DMS B1007 4 HET 37J B1008 35 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM 37J 2-{[2-(TRIFLUOROMETHOXY)BENZOYL]AMINO}-N-[6- HETNAM 2 37J (TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL]-1,3-THIAZOLE- HETNAM 3 37J 4-CARBOXAMIDE HETNAM DMS DIMETHYL SULFOXIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 3 SO4 8(O4 S 2-) FORMUL 7 GOL 3(C3 H8 O3) FORMUL 8 BOG 2(C14 H28 O6) FORMUL 9 37J 2(C20 H11 F6 N5 O3 S) FORMUL 17 DMS C2 H6 O S FORMUL 19 HOH *837(H2 O) HELIX 1 AA1 GLN A 48 GLN A 60 1 13 HELIX 2 AA2 SER A 88 CYS A 96 1 9 HELIX 3 AA3 SER A 101 LYS A 122 1 22 HELIX 4 AA4 LYS A 130 ASP A 132 5 3 HELIX 5 AA5 LEU A 138 GLY A 142 5 5 HELIX 6 AA6 THR A 176 ALA A 180 5 5 HELIX 7 AA7 SER A 181 LEU A 186 1 6 HELIX 8 AA8 SER A 191 GLY A 209 1 19 HELIX 9 AA9 ARG A 222 THR A 235 1 14 HELIX 10 AB1 PRO A 236 CYS A 241 1 6 HELIX 11 AB2 SER A 246 LEU A 258 1 13 HELIX 12 AB3 ASP A 265 GLN A 280 1 16 HELIX 13 AB4 GLN B 48 GLN B 60 1 13 HELIX 14 AB5 SER B 88 CYS B 96 1 9 HELIX 15 AB6 SER B 101 LYS B 122 1 22 HELIX 16 AB7 LYS B 130 ASP B 132 5 3 HELIX 17 AB8 LEU B 138 GLY B 142 5 5 HELIX 18 AB9 SER B 181 LEU B 186 1 6 HELIX 19 AC1 SER B 191 GLY B 209 1 19 HELIX 20 AC2 GLN B 223 SER B 234 1 12 HELIX 21 AC3 PRO B 236 CYS B 241 1 6 HELIX 22 AC4 SER B 246 LEU B 258 1 13 HELIX 23 AC5 ASP B 265 GLN B 280 1 16 SHEET 1 AA1 6 LEU A 3 VAL A 5 0 SHEET 2 AA1 6 TYR A 9 GLY A 16 -1 O LEU A 11 N LEU A 3 SHEET 3 AA1 6 ASP A 22 ASP A 28 -1 O ILE A 23 N ILE A 15 SHEET 4 AA1 6 GLU A 33 CYS A 41 -1 O GLU A 33 N ASP A 28 SHEET 5 AA1 6 TYR A 77 GLU A 83 -1 O MET A 82 N ALA A 36 SHEET 6 AA1 6 ILE A 68 GLU A 74 -1 N TRP A 70 O VAL A 81 SHEET 1 AA2 2 PHE A 124 ILE A 125 0 SHEET 2 AA2 2 LYS A 154 LYS A 155 -1 O LYS A 154 N ILE A 125 SHEET 1 AA3 2 PHE A 134 MET A 136 0 SHEET 2 AA3 2 VAL A 145 ILE A 147 -1 O TYR A 146 N LEU A 135 SHEET 1 AA4 6 ARG B 4 VAL B 5 0 SHEET 2 AA4 6 TYR B 9 SER B 17 -1 O TYR B 9 N VAL B 5 SHEET 3 AA4 6 ASP B 22 ASP B 28 -1 O LEU B 25 N ASN B 13 SHEET 4 AA4 6 GLU B 33 CYS B 41 -1 O GLU B 33 N ASP B 28 SHEET 5 AA4 6 TYR B 77 GLU B 83 -1 O MET B 80 N LYS B 38 SHEET 6 AA4 6 ILE B 68 GLU B 74 -1 N TRP B 70 O VAL B 81 SHEET 1 AA5 2 PHE B 124 ILE B 125 0 SHEET 2 AA5 2 LYS B 154 LYS B 155 -1 O LYS B 154 N ILE B 125 SHEET 1 AA6 2 PHE B 134 MET B 136 0 SHEET 2 AA6 2 VAL B 145 ILE B 147 -1 O TYR B 146 N LEU B 135 CISPEP 1 LYS A 221 ARG A 222 0 11.46 CRYST1 52.040 134.721 56.845 90.00 99.68 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019216 0.000000 0.003278 0.00000 SCALE2 0.000000 0.007423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017846 0.00000